Montelparo study: Risk factors for age-Related macular degeneration in a little rural community in Italy

Clinica Terapeutica

Volumn 160, Issue 3, 2009, Pages

  Carresi, C ^a   Cruciani, F ^a   Paolucci, F ^a   Curto, T ^a   Mazzeo, L ^a   Cuozzo, G ^a   Moramarco, A ^a   Gharbiya, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Age related macular degeneration; Epidemiology; Ophthalmic health; Risk factors; Rural community

Indexed keywords

AGED; ARTICLE; FEMALE; HEALTH; HUMAN; ITALY; MALE; PREVALENCE; RETINA MACULA DEGENERATION; RISK FACTOR;

AGED; FEMALE; HUMANS; ITALY; MACULAR DEGENERATION; MALE; PREVALENCE; RISK FACTORS; RURAL HEALTH;

EID: 79961026820     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Friedman DS, O'Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564-72
2. Krishnaiah S, Das T, Nirmalan PK, et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol Vis Sci 2005; 46:4442-9
3. Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: The Copenhagen City Eye Study. Ophthalmology 2001; 108:2347-57
4. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116:653-8
5. Evans JR, Fletcher AE, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 2004; 111:513-7
6. Stein JD, Brown MM, Brown GC, et al. Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br J Ophthalmol 2003; 87:8-12
7. Augood CA, Vingerling JR, de Jong PT, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006; 124:529-35
8. Cedrone C, Nucci C, Scuderi G, et al. Prevalence of blindness and low vision in an Italian population: a comparison with other European studies. Eye 2006; 20:661-7
9. Pagliarini S, Moramarco A, Wormald RP, et al. Age-related macular disease in rural southern Italy. Arch Ophthalmol 1997; 115:616-22
10. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic colour fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132:668-81
11. Van Leeuwen R, Chakravarthy U, Vingerling JR, et al. Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmol 2003; 110:1540-4
12. Klein R, Davis MD, Magli YL, et al. The Wisconsin agerelated maculopathy grading system. Ophthalmol 1991; 98:1128-34
13. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39:367-74
14. Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmol 2006; 113:260-6
15. Scholl HP, Peto T, Dandekar S, et al. Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. Graefes Arch Clin Exp Ophthalmol 2003; 241:39-47
16. Siegel S, Castellan NJ. Nonparametric Statistics for The Behavioral Sciences. New York: McGraw-Hill, 1988
17. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmol 2002; 109:1767-79
18. Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005; 83:400-1
19. Nucci C, Cedrone C, Culasso F, et al. Incidence of visual loss in the Ponza Eye Study, Italy. Eye 2005; 19:175-82
20. Klein R, Klein BE, Wang Q, et al. Is age-related maculopathy associated with cataracts? Arch Ophthalmol 1994; 112:191-6
21. Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 1998; 82:996-1002
22. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmol 2000; 107:2224-32
23. McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001; 119:1455-62
24. Klein R, Klein BE, Jensen SC, et al. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998; 116:506-13
25. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995; 142:404-9
26. Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000; 118:351-8
27. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol 1986; 104:216-9
28. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 369:425-35
29. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 1999; 20:573-600
30. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119:1417-36
31. Richer S, Stiles W, Statkute L, et al. Double-masked, placebocontrolled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004; 75:216-30
32. Sanders TA, Haines AP, Wormald R, et al. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 1993; 57:428-33
33. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 2007; 84:718-28
34. Fraser-Bell S, Wu J, Klein R, et al. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006; 141:79-87
35. Obisesan TO, Hirsch R, Kosoko O, et al. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J Am Geriatr Soc 1998; 46:1-7
36. Arnarsson A, Sverrisson T, Stefánsson E, et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 2006; 142:419-28
37. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997; 25:13-5
38. Guymer RH, Chiu AW, Lim L, et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Surv Ophthalmol 2005; 50:194-206
39. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001; 119:1191-9
40. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001; 73:209-18
41. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004; 111:1280-7
42. Tan JS, Mitchell P, Rochtchina E, et al. Statins and the longterm risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol 2007; 143:685-7
43. Kark JD, Kaufmann NA, Binka F, et al. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 2003; 77:796-802
44. Delcourt C, Carrière I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. Arch Ophthalmol 2001; 119:1463-8
45. Tomany SC, Cruickshanks KJ, Klein R, et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2004; 122:750-7
46. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001; 20:227-53
47. Evans JR, Fletcher AE, Wormald RP. 28.000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005; 89:550-3
48. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmol 2001; 108:697-704
49. Khan JC, Thurlby DA, Shahid H, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006; 90:75-80
50. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276:1141-6
51. Klein BE, Klein R, Lee KE, et al. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 2001; 8:251-62
52. Delcourt C, Michel F, Colvez A, et al. POLA Study Group. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 2001; 8:237-49
53. Seddon JM, Cote J, Davis N, et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003; 121:785-92
54. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992; 110:1701-8